Celcuity (CELC) Competitors $10.24 +0.25 (+2.50%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$10.26 +0.02 (+0.15%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELC vs. AHCO, TDOC, CDNA, AVAH, VRDN, PNTG, GRAL, FTRE, CSTL, and FLGTShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include AdaptHealth (AHCO), Teladoc Health (TDOC), CareDx (CDNA), Aveanna Healthcare (AVAH), Viridian Therapeutics (VRDN), The Pennant Group (PNTG), Grail (GRAL), Fortrea (FTRE), Castle Biosciences (CSTL), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. Celcuity vs. AdaptHealth Teladoc Health CareDx Aveanna Healthcare Viridian Therapeutics The Pennant Group Grail Fortrea Castle Biosciences Fulgent Genetics AdaptHealth (NASDAQ:AHCO) and Celcuity (NASDAQ:CELC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment, institutional ownership and community ranking. Which has more volatility & risk, AHCO or CELC? AdaptHealth has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Do institutionals and insiders hold more shares of AHCO or CELC? 82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 4.4% of AdaptHealth shares are held by insiders. Comparatively, 15.8% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is AHCO or CELC more profitable? Celcuity has a net margin of 0.00% compared to AdaptHealth's net margin of -6.57%. AdaptHealth's return on equity of 9.62% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets AdaptHealth-6.57% 9.62% 3.18% Celcuity N/A -62.66%-39.78% Does the MarketBeat Community prefer AHCO or CELC? Celcuity received 253 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 67.79% of users gave Celcuity an outperform vote while only 62.41% of users gave AdaptHealth an outperform vote. CompanyUnderperformOutperformAdaptHealthOutperform Votes8862.41% Underperform Votes5337.59% CelcuityOutperform Votes34167.79% Underperform Votes16232.21% Which has higher earnings & valuation, AHCO or CELC? Celcuity has lower revenue, but higher earnings than AdaptHealth. Celcuity is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptHealth$3.26B0.32-$678.90M$0.6012.98CelcuityN/AN/A-$63.78M-$2.81-3.64 Does the media favor AHCO or CELC? In the previous week, AdaptHealth had 3 more articles in the media than Celcuity. MarketBeat recorded 4 mentions for AdaptHealth and 1 mentions for Celcuity. AdaptHealth's average media sentiment score of 0.43 beat Celcuity's score of 0.00 indicating that AdaptHealth is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate AHCO or CELC? AdaptHealth presently has a consensus target price of $13.80, suggesting a potential upside of 77.15%. Celcuity has a consensus target price of $30.17, suggesting a potential upside of 194.60%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than AdaptHealth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AdaptHealth 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Celcuity 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 SummaryCelcuity beats AdaptHealth on 10 of the 18 factors compared between the two stocks. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$387.47M$2.78B$5.30B$7.34BDividend YieldN/A31.37%5.12%4.30%P/E Ratio-3.9214.4621.8017.78Price / SalesN/A192.58379.9697.74Price / CashN/A57.5638.2634.64Price / Book1.874.486.443.97Net Income-$63.78M-$22.21M$3.21B$247.65M7 Day Performance10.94%1.82%2.85%1.80%1 Month Performance1.49%-6.62%-8.64%-6.98%1 Year Performance-37.52%6.40%11.38%1.34% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity1.3247 of 5 stars$10.24+2.5%$30.17+194.6%-39.8%$387.47MN/A-3.9240AHCOAdaptHealth3.6737 of 5 stars$9.56-5.3%$13.80+44.4%-17.4%$1.29B$3.26B-5.7910,900TDOCTeladoc Health3.752 of 5 stars$7.23-0.9%$11.26+55.9%-48.0%$1.25B$2.57B-1.255,100Upcoming EarningsShort Interest ↓Gap UpCDNACareDx3.6697 of 5 stars$17.72+2.5%$31.83+79.6%+112.8%$982.15M$333.79M-6.56740Analyst ForecastPositive NewsGap UpAVAHAveanna Healthcare0.8907 of 5 stars$4.96-1.4%$4.94-0.5%+104.5%$967.67M$2.02B-14.5933,000News CoverageGap UpHigh Trading VolumeVRDNViridian Therapeutics1.0876 of 5 stars$11.78-1.8%$35.70+203.1%-12.9%$959.89M$302,000.00-2.7350News CoveragePositive NewsPNTGThe Pennant Group3.2813 of 5 stars$24.35-0.9%$34.80+42.9%+30.6%$838.37M$695.24M35.815,340Positive NewsGRALGrail0.7812 of 5 stars$23.98+7.8%$20.00-16.6%N/A$812.80M$125.60M0.001,360Short Interest ↑News CoveragePositive NewsFTREFortrea3.7324 of 5 stars$6.27-2.9%$19.00+203.0%-85.5%$565.55M$2.70B-1.8318,000Short Interest ↓CSTLCastle Biosciences3.0262 of 5 stars$19.09+2.8%$38.75+103.0%+14.2%$550.54M$332.07M95.45540FLGTFulgent Genetics3.5127 of 5 stars$17.10+1.4%$16.00-6.4%-11.1%$527.81M$283.47M-3.101,010Positive News Related Companies and Tools Related Companies AdaptHealth Competitors Teladoc Health Competitors CareDx Competitors Aveanna Healthcare Competitors Viridian Therapeutics Competitors The Pennant Group Competitors Grail Competitors Fortrea Competitors Castle Biosciences Competitors Fulgent Genetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELC) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.